Vessella Theadora, Rozen Esteban J, Shohet Jason, Wen Qi, Zhou Hong Susan
Department of Chemical Engineering, Worcester Polytechnic Institute, 100 Institute Rd., Worcester, MA 01609, USA.
Crnic Institute Bolder Branch, BioFrontiers Institute, University of Colorado Boulder, 3415 Colorado Avenue, Boulder, CO 80303, USA.
Life (Basel). 2024 Oct 2;14(10):1260. doi: 10.3390/life14101260.
Neuroblastoma is a devastating disease accounting for ~15% of all childhood cancer deaths. Collagen content and fiber association within the tumor stroma influence tumor progression and metastasis. High expression levels of collagen receptor kinase, Discoidin domain receptor II (DDR2), are associated with the poor survival of neuroblastoma patients. Additionally, cancer cells generate and sustain mechanical forces within their environment as a part of their normal physiology. Despite this, evidence regarding whether collagen-activated DDR2 signaling dysregulates these migration forces is still elusive. To address these questions, a novel shRNA DDR2 knockdown neuroblastoma cell line (SH-SY5Y) was engineered to evaluate the consequence of DDR2 on cellular mechanics. Atomic force microscopy (AFM) and traction force microscopy (TFM) were utilized to unveil the biophysical altercations. DDR2 downregulation was found to significantly reduce proliferation, cell stiffness, and cellular elongation. Additionally, DDR2-downregulated cells had decreased traction forces when plated on collagen-coated elastic substrates. Together, these results highlight the important role that DDR2 has in reducing migration mechanics in neuroblastoma and suggest DDR2 may be a promising novel target for future therapies.
神经母细胞瘤是一种毁灭性疾病,约占儿童癌症死亡总数的15%。肿瘤基质中的胶原蛋白含量和纤维关联会影响肿瘤进展和转移。胶原蛋白受体激酶盘状结构域受体II(DDR2)的高表达水平与神经母细胞瘤患者的不良生存率相关。此外,癌细胞在其微环境中产生并维持机械力,这是其正常生理功能的一部分。尽管如此,关于胶原蛋白激活的DDR2信号传导是否会失调这些迁移力的证据仍然不明确。为了解决这些问题,构建了一种新型的DDR2短发夹RNA(shRNA)敲低神经母细胞瘤细胞系(SH-SY5Y),以评估DDR2对细胞力学的影响。利用原子力显微镜(AFM)和牵引力显微镜(TFM)揭示生物物理变化。发现DDR2下调会显著降低细胞增殖、细胞硬度和细胞伸长。此外,当接种在胶原蛋白包被的弹性基质上时,DDR2下调的细胞牵引力降低。总之,这些结果突出了DDR2在降低神经母细胞瘤迁移力学方面的重要作用,并表明DDR2可能是未来治疗的一个有前景的新靶点。